Mark K. Wedel

Potent Reduction of Apolipoprotein B and Low-Density Lipoprotein Cholesterol by Short-Term Administration of an Antisense Inhibitor of Apolipoprotein B

John J.P. Kastelein, Mark K. Wedel, Brenda F. Baker et al. · Circulation · 2006 · 356 citations · Full text

Partial Liquid Ventilation in Adult Patients with Acute Respiratory Distress Syndrome

Robert M. Kacmarek, Herbert Wiedemann, Philip T. Lavin et al. · American Journal of Respiratory and Critical Care Medicine · 2005 · 163 citations

Efficacy and Safety of Mipomersen, an Antisense Inhibitor of Apolipoprotein B, in Hypercholesterolemic Subjects Receiving Stable Statin Therapy

Fatima Akdim, Erik S.G. Stroes, Eric J.G. Sijbrands et al. · Journal of the American College of Cardiology · 2010 · 160 citations

Antisense Inhibitor, Oxysterol, Cardiovascular Disease +7

An enema formulation of alicaforsen, an antisense inhibitor of intercellular adhesion molecule‐1, in the treatment of chronic, unremitting pouchitis

Philip B. Miner, Mark K. Wedel, Barbara L. Bane et al. · Alimentary Pharmacology & Therapeutics · 2004 · 137 citations · Full text

A Phase II dose ranging, double‐blind, placebo‐controlled study of alicaforsen enema in subjects with acute exacerbation of mild to moderate left‐sided ulcerative colitis

Sander J. H. van Deventer, Mark K. Wedel, Brenda F. Baker et al. · Alimentary Pharmacology & Therapeutics · 2006 · 126 citations · Full text